Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma
NCT00076011
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Neoplasms
Interventions
DRUG:
Vascular Endothelial Growth Factor Receptor [VEGFR] and Platelet-Derived Growth Factor Receptor [PDGFR] inhibitor
Sponsor
Pfizer